[go: up one dir, main page]

NO20071458L - Nanopartikkel og fremgangsmate for fremstilling av denne - Google Patents

Nanopartikkel og fremgangsmate for fremstilling av denne

Info

Publication number
NO20071458L
NO20071458L NO20071458A NO20071458A NO20071458L NO 20071458 L NO20071458 L NO 20071458L NO 20071458 A NO20071458 A NO 20071458A NO 20071458 A NO20071458 A NO 20071458A NO 20071458 L NO20071458 L NO 20071458L
Authority
NO
Norway
Prior art keywords
gelatin
preparation
nanoparticle
maximum
nanoparticles
Prior art date
Application number
NO20071458A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of NO20071458L publication Critical patent/NO20071458L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO20071458A 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne NO20071458L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO20071458L true NO20071458L (no) 2007-03-19

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071458A NO20071458L (no) 2004-08-20 2007-03-19 Nanopartikkel og fremgangsmate for fremstilling av denne

Country Status (14)

Country Link
US (1) US20080003292A1 (de)
EP (1) EP1793810A1 (de)
JP (1) JP2008510688A (de)
KR (1) KR20070046850A (de)
CN (1) CN1988892A (de)
AU (1) AU2005276675A1 (de)
BR (1) BRPI0514524A (de)
CA (1) CA2575407A1 (de)
DE (1) DE102004041340A1 (de)
IL (1) IL180954A0 (de)
MX (1) MX2007001996A (de)
NO (1) NO20071458L (de)
NZ (1) NZ551326A (de)
WO (1) WO2006021367A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ569741A (en) 2005-12-14 2012-02-24 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
EP1968649A4 (de) * 2005-12-20 2012-12-19 Fujifilm Corp Protein-nanoteilchen und ihre verwendung
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
JP5437797B2 (ja) 2006-06-12 2014-03-12 サイトス バイオテクノロジー アーゲー Ｒｎａバクテリオファージのウイルス様粒子にオリゴヌクレオチドをパッケージ化するための方法
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
EP1970077B1 (de) * 2007-03-16 2009-10-14 National Chi Nan University Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
JP6054299B2 (ja) 2010-11-10 2016-12-27 リージェンメド（ケイマン）エルティーディー． 臓器強化のための注射可能な製剤
EP2540287A1 (de) 2011-07-01 2013-01-02 FutureChemistry Fließfertigung von Gelatine-Nanoteilchen
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
WO2017110745A1 (ja) 2015-12-25 2017-06-29 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
CA3010995A1 (en) * 2016-01-25 2017-08-03 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
WO2021206440A1 (ko) * 2020-04-09 2021-10-14 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법
US20240049705A1 (en) * 2022-07-26 2024-02-15 Industry Foundation Of Chonnam National University Composition for enhancing growth of plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
ES2087565T3 (es) * 1991-12-05 1996-07-16 Alfatec Pharma Gmbh Nanosol aplicable farmaceuticamente y procedimiento para su preparacion.
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
ATE312623T1 (de) * 1999-04-08 2005-12-15 Univ Johns Hopkins Antigen-spezifische induktion der peripheren immuntoleranz
ATE487470T1 (de) * 2002-09-11 2010-11-15 Elan Pharma Int Ltd Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
US20080003292A1 (en) 2008-01-03
KR20070046850A (ko) 2007-05-03
IL180954A0 (en) 2007-07-04
EP1793810A1 (de) 2007-06-13
JP2008510688A (ja) 2008-04-10
NZ551326A (en) 2010-04-30
MX2007001996A (es) 2007-05-10
DE102004041340A1 (de) 2006-02-23
BRPI0514524A (pt) 2008-06-10
CA2575407A1 (en) 2006-03-02
WO2006021367A1 (de) 2006-03-02
AU2005276675A1 (en) 2006-03-02
CN1988892A (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
NO20071458L (no) Nanopartikkel og fremgangsmate for fremstilling av denne
Hsu et al. Self-powered and plant-wearable hydrogel as LED power supply and sensor for promoting and monitoring plant growth in smart farming
WO2007077399A3 (fr) Gel viscoelastique a usage dermatologique
BR0307962A (pt) Preparação cosmética
CO5540367A2 (es) Composicion de liberacion controlada y metodo para producirla
TR200200649T2 (tr) Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
DE60222007D1 (de) Polymermicellenzusammensetzung mit verbesserter stabilität
WO2008129106A3 (es) Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones
Li et al. Carbon dot/poly (methylacrylic acid) nanocomposite hydrogels with high toughness and strong fluorescence
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
Li et al. Photocontrollable water-soluble polymeric hydrogen sulfide (H2S) donor
WO2008067436A3 (en) Compounds and formulations suitable for radical scavenging
Mintz et al. Development of red-emissive carbon dots for bioimaging through a building block approach: Fundamental and applied studies
Sun et al. A bio-inspired approach for in situ synthesis of tunable adhesive
Yong et al. The unexplored potential of gas‐responsive polymers in drug delivery: progress, challenges and outlook
Bao et al. Self‐assembly of a renewable lignin biopolymer in nanoparticles with multiple morphologies
WO2004089992A8 (ja) 改質アラビアガムおよびその用途
WO2010001267A3 (en) Delivery product for topical compositions
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
CN111701033A (zh) 一种聚苯胺-金-氧化酶纳米颗粒的制备方法及其应用
ITMI20032498A1 (it) Polisaccaridi antitrombotici a basso peso molecolare e
Gan et al. Preparation and physicochemical properties of coenzyme Q10 loaded niosomal hydrogels based on carbomer and scleroglucan
CN103881725B (zh) 一种林蛙皮冻干粉的制备方法
WO2008102144A3 (en) Aqueous formulations
CN115605583A (zh) 一种诱导胶质细胞转分化为功能性神经元的方法及其应用

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application